يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Ferraccioli, Gianfranco"', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, SEBASTIANI, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthriti, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; https://hdl.handle.net/11381/2977650Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    https://hdl.handle.net/11381/2977650Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11577/3277137Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11577/3277137Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Ramonda, Roberta, Lapadula, Giovanni, Bergossi, Francesca, SEBASTIANI, Marco

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11380/1138105Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11380/1138105Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10Â years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11570/3125483Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11570/3125483Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register

    المؤلفون: Iannone, Florenzo, Gremese, Elisa, Gallo, Gaia, Sarzi-Puttini, Piercarlo, Botsios, Costantino, Trotta, Francesco, Gasperini, Stefania, Galeazzi, Mauro, Adami, Silvano, Cantini, Fabrizio, Sebastiani, Marco, Gorla, Roberto, Marchesoni, Antonio, Giardina, Annarita, Foti, Rosario, Mele, Angiola, Bruschi, Eleonora, Bagnato, Gianluca, Erre, Gian Luca, Lapadula, Giovanni, Scioscia, Crescenzio, Fedele, Anna Laura, Ferraccioli, Gianfranco, Atzeni, Fabiola, Bongiovanni, Sara, Punzi, Leonardo, Bernardi, Livio, Bagnari, Valentina, Govoni, Marcello, Grassi, Walter, Salaffi, Fausto, Manganelli, Stefania, Frati, Elena, Carletto, Antonio, Caimmi, Cristian, Palloni, Alice, Niccoli, Laura, Ferri, Clodoveo, Favalli, Ennio Giulio, Triolo, Giovanni, Di Gangi, Marcella

    المساهمون: Iannone, Florenzo, Gremese, Elisa, Gallo, Gaia, Sarzi-Puttini, Piercarlo, Botsios, Costantino, Trotta, Francesco, Gasperini, Stefania, Galeazzi, Mauro, Adami, Silvano, Cantini, Fabrizio, Sebastiani, Marco, Gorla, Roberto, Marchesoni, Antonio, Giardina, Annarita, Foti, Rosario, Mele, Angiola, Bruschi, Eleonora, Bagnato, Gianluca, Erre, Gian Luca, Lapadula, Giovanni, Scioscia, Crescenzio, Fedele, Anna Laura, Ferraccioli, Gianfranco, Atzeni, Fabiola, Bongiovanni, Sara, Punzi, Leonardo, Bernardi, Livio, Bagnari, Valentina, Govoni, Marcello, Grassi, Walter, Salaffi, Fausto, Manganelli, Stefania, Frati, Elena, Carletto, Antonio, Caimmi, Cristian, Palloni, Alice, Niccoli, Laura, Ferri, Clodoveo, Favalli, Ennio Giulio, Triolo, Giovanni, Di Gangi, Marcella

    مصطلحات موضوعية: DAS28, Disease remission, GISEA, HAQ, TNF-α inhibitor, Adolescent, Adult, Aged, 80 and over, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Drug Therapy, Combination, Etanercept, Female, Glucocorticoid, Human, Immunoglobulin G, Italy, Male, Methotrexate, Middle Aged, Prospective Studie, Receptors, Tumor Necrosis Factor, Registrie, Severity of Illness Index, Surveys and Questionnaire

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/23954923; info:eu-repo/semantics/altIdentifier/wos/WOS:000329941600005; volume:33; issue:1; firstpage:31; lastpage:37; numberofpages:7; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11566/254519Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84897631607; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-013-2348-6Test
    http://hdl.handle.net/11566/254519Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy

    المؤلفون: Caporali, Roberto, Conti, Fabrizio, Alivernini, Stefano, Atzeni, Fabiola, Seriolo, Bruno, Cutolo, Maurizio, Valesini, Guido, Ferraccioli, Gianfranco, Sarzi Puttini, Piercarlo, Guiducci, Serena, Zampogna, Giuseppe, Gremese, Elisa, Pipitone, Nicolo', Scrivo, Rossana, Bugatti, Serena, Montecucco, Carlomaurizio, Matucci Cerinic, Marco, SALVARANI, CARLO

    المساهمون: Caporali, Roberto, Conti, Fabrizio, Alivernini, Stefano, Atzeni, Fabiola, Seriolo, Bruno, Cutolo, Maurizio, Valesini, Guido, Ferraccioli, Gianfranco, Sarzi Puttini, Piercarlo, Salvarani, Carlo, Guiducci, Serena, Zampogna, Giuseppe, Gremese, Elisa, Pipitone, Nicolo', Scrivo, Rossana, Bugatti, Serena, Montecucco, Carlomaurizio, Matucci Cerinic, Marco

    مصطلحات موضوعية: Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Biological Therapy, Evidence-Based Medicine, Human, Italy, Patient Selection, Rheumatology, Societies, Medical, Treatment Outcome

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21906423; info:eu-repo/semantics/altIdentifier/wos/WOS:000295352000002; volume:29; firstpage:S7; lastpage:S14; journal:CLINICAL AND EXPERIMENTAL RHEUMATOLOGY; http://hdl.handle.net/11380/1078934Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-80055068987

    الإتاحة: http://hdl.handle.net/11380/1078934Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث